Randomized, Multicenter Study to Find Optimal Treatment Duration in Patients With Chronic Hepatitis C and Subtype 1 or 4 Depending on HCV RNA Level at Week 8 and Week 12
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Roche
- 07 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 17 Oct 2009 Status changed from not yet recruiting to recruiting as reported by Roche.
- 21 Aug 2009 Status changed from recruiting to not yet recruiting as reported by Roche record.